BCL2L11 and malignant colon neoplasm: These findings suggest that FOXO3a functions as a direct transcriptional regulator of Bim expression in lung cancer cell lines, which is consistent with previous reports in breast cancer [6], NSCLC [9], colon cancer [25] and leukemia [26].